Investment Summary

EQT Life Sciences Invests In eTheRNA

On March 14, 2016, growth capital firm EQT Life Sciences invested in life science company eTheRNA

Investment Highlights
  • This is EQT Life Sciences’ 3rd transaction in the Life Science sector.
  • This is EQT Life Sciences’ 1st transaction in Belgium.

Investment Summary

Date 2016-03-14
Target eTheRNA
Sector Life Science
Investor(s) EQT Life Sciences
Deal Type Venture

Target

eTheRNA

Niel, Belgium
eTheRNA is developing its proprietary TriMix mRNA-based immunotherapies for melanoma, breast cancer and infectious diseases. eTheRNA was founded in 2013 and is based in Niel, Belgium.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 9 of 47
Sector: Life Science M&A 3 of 30
Type: Venture M&A Deals 7 of 39
Country: Belgium M&A 1 of 5
Year: 2016 M&A 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-20 Kaleido

Utrecht, Netherlands

Kaleido is a medical product company commercializing the Kaleido insulin pump system for diabetes patients. Kaleido was founded in 2013 and is based in Utrecht, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-19 Onwards

Eindhoven, Netherlands

Onwards is a developer of implantable neuro stimulator for patients with incomplete spinal cord injury. Onwards was founded in 2014 and is based in Eindhoven, Netherlands.

Buy -